These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23184212)

  • 1. Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.
    Gonçalves AC; Gebrim EM; Monteiro ML
    Clinics (Sao Paulo); 2012 Nov; 67(11):1327-34. PubMed ID: 23184212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between computed tomography and magnetic resonance imaging in Graves' orbitopathy.
    Nianiaris N; Hurwitz JJ; Chen JC; Wortzman G
    Can J Ophthalmol; 1994 Feb; 29(1):9-12. PubMed ID: 8180879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features.
    Konuk O; Onaran Z; Ozhan Oktar S; Yucel C; Unal M
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1555-9. PubMed ID: 19609549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy.
    Lešin M; Rogošić V; Vanjaka Rogošić L; Barišić I; Pelčić G
    Acta Clin Croat; 2018 Jun; 57(2):301-306. PubMed ID: 30431723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' orbitopathy: current imaging procedures.
    Kirsch E; Hammer B; von Arx G
    Swiss Med Wkly; 2009 Oct; 139(43-44):618-23. PubMed ID: 19950023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in Graves' orbitopathy.
    Kirsch E; von Arx G; Hammer B
    Orbit; 2009; 28(4):219-25. PubMed ID: 19839878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
    Pascual-Camps I; Molina-Pallete R; Bort-Martí MA; Todolí J; España-Gregori E
    Orbit; 2018 Dec; 37(6):450-453. PubMed ID: 29420104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern electroretinogram (PERG) in the early diagnosis of optic nerve dysfunction in the course of Graves' orbitopathy.
    Przemysław P; Janusz M; Alina BŁ; Maria G
    Klin Oczna; 2013; 115(1):9-12. PubMed ID: 23882731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the surgical management of Graves' orbitopathy.
    Baeg J; Choi HS; Kim C; Kim H; Jang SY
    Front Endocrinol (Lausanne); 2022; 13():1080204. PubMed ID: 36824601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.
    Ambrosio G; Ferrara G; Vitale R; De Marco R
    Doc Ophthalmol; 2003 Mar; 106(2):99-104. PubMed ID: 12678273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures.
    Gonçalves AC; Silva LN; Gebrim EM; Matayoshi S; Monteiro ML
    Clinics (Sao Paulo); 2012 Aug; 67(8):891-6. PubMed ID: 22948455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of multifocal visual evoked potentials in patients with Graves' orbitopathy and subclinical optic nerve involvement.
    Pérez-Rico C; Rodríguez-González N; Arévalo-Serrano J; Blanco R
    Doc Ophthalmol; 2012 Aug; 125(1):11-9. PubMed ID: 22581376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysthyroid optic neuropathy: evaluation and management.
    Dolman PJ
    J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab.
    Hwang CJ; Nichols EE; Chon BH; Perry JD
    Eur J Ophthalmol; 2022 May; 32(3):NP46-NP49. PubMed ID: 33525898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.
    Sio SWC; Chan BKT; Aljufairi FMAA; Sebastian JU; Lai KKH; Tham CCY; Pang CP; Chong KKL
    Surv Ophthalmol; 2024; 69(3):403-410. PubMed ID: 38007201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of optic neuropathy in endocrine orbitopathy].
    Heinemann B; Bischoff P; Jörgensen J; Weder B
    Klin Monbl Augenheilkd; 1991 May; 198(5):460-1. PubMed ID: 1886385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic neuropathy secondary to granulomatosis with polyangiitis in a patient with Graves' disease: a case report.
    Sato-Akushichi M; Kinouchi R; Kawai N; Nomura K
    J Med Case Rep; 2021 Dec; 15(1):618. PubMed ID: 34963497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT scan evidence of dysthyroid optic neuropathy.
    Giaconi JA; Kazim M; Rho T; Pfaff C
    Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):177-82. PubMed ID: 12021647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysthyroid optic neuropathy: emerging treatment strategies.
    Pelewicz-Sowa M; Miśkiewicz P
    J Endocrinol Invest; 2023 Jul; 46(7):1305-1316. PubMed ID: 36802028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.